Virtus Biotech Clinical TriaBBCETF
13F holders, Q1 2026 (March 31)20holders +1
5new positions
4sold out
1famous investor
$41.70avg. 13F price*
At the end of Q1 2026, 20 institutions reported holding Virtus Biotech Clinical Tria (BBC) in their 13F filings, up 1 from Q4 2025. 5 opened new positions and 4 sold out. The largest holders were Kera Capital Partners, Inc. ($3.7M), Susquehanna International Group, LLP ($2.2M) and Militia Capital Management LLC ($1.9M). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Virtus Biotech Clinical Tria
- Filed as
- ETFIS SER TR I (Q1 2026)
- CUSIP
- 26923G301
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $1.8M |
| Exits | 4 | $1.3M |
All 13F filers, Q4 2025 → Q1 2026: 77,767 shares bought and 54,662 shares sold, net +23,105 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 20 holders
| Kera Capital Partners, Inc. | 0.46% | Add +5.2% | 89,364 | $3.7M |
| Susquehanna International Group, LLP | 0.00% | Add +137.0% | 52,053 | $2.2M |
| Militia Capital Management LLC | 0.43% | — | 45,663 | $1.9M |
| Citadel Advisors | 0.00% | Reduce -31.4% | 28,084 | $1.2M |
| Quantinno Capital Management LP | 0.00% | New | 19,383 | $807K |
| Morgan Stanley | 0.00% | Reduce -9.6% | 15,236 | $634K |
| LPL Financial LLC | 0.00% | Add +0.9% | 12,432 | $517K |
| Aurora Private Wealth, Inc. | 0.34% | New | 11,376 | $474K |
| Flow Traders U.S. LLC | 0.01% | New | 10,378 | $432K |
| Jane Street Group, LLC | 0.00% | Reduce -4.5% | 7,575 | $315K |
| Global Assets Advisory, LLC | 0.03% | New | 2,000 | $104K |
| Dynamic Wealth Strategies, LLC | 0.02% | No change | 927 | $39K |
| Osaic Holdings, Inc. | 0.00% | Reduce -6.2% | 757 | $32K |
| Group One Trading LLC | 0.00% | Reduce -80.9% | 300 | $12K |
| New England Capital Financial Advisors LLC | 0.00% | No change | 158 | $7K |
| UBS Group AG | 0.00% | Reduce -97.3% | 136 | $6K |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 110 | $5K |
| Blair William & Co. | 0.00% | New | 28 | $1K |
| Larson Financial Group LLC | 0.00% | No change | 20 | $832 |
| Allworth Financial LP | 0.00% | No change | 10 | $417 |
"% of holder's portfolio" is BBC's weight in each manager's 13F, not the share of Virtus Biotech Clinical Tria the manager owns.